NCCIH Natural Product Mid Phase Clinical Trial
Funds the mid-phase study that settles a natural product's dose, formulation or responder group before anyone commits to a multi-site efficacy trial.
This is the third and last step of the natural product pathway, and the one that decides what a full efficacy trial would actually test.
The entry condition is heavy. An application must bring preliminary data showing bioavailability where that applies, and documentation that the product produces a reproducible, measurable impact on target engagement — the mechanism of action, measured. That requ…
Mid-phase clinical trials of natural products — botanicals, dietary supplements, probiotics and standardised nutritional regimens — determining optimal dose or formulation, or identifying responder and non-responder phenotypes, ahead of a future multi-site efficacy trial. Requires preliminary bioavailability and reproducible target-engagement data. Efficacy and effectiveness trials are not supported.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up